Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,029	1,982	1,584	1,465	999	1,903
Market Cap Growth	47.58%	25.12%	8.13%	46.67%	-47.51%	158.03%
Enterprise Value	2,193	1,602	1,033	1,295	552	1,542
Last Close Price	10.76	8.45	13.80	17.42	13.54	30.65
PS Ratio	356.34	18.13	-	-	-	-
PB Ratio	3.79	1.76	3.48	5.07	2.61	5.37
P/TBV Ratio	3.79	1.76	3.50	6.63	3.16	6.71
EV/Sales Ratio	258.01	14.65	-	-	-	-
Debt / Equity Ratio	-	-	-	0	0.00	0
Asset Turnover	0.01	0.13	-	-	-	-
Quick Ratio	13.49	16.13	11.86	5.69	5.67	6.81
Current Ratio	13.86	16.50	12.10	5.81	5.75	6.82
Return on Equity (ROE)	-72.16%	-21.28%	-83.53%	-85.79%	-80.37%	-43.44%
Return on Assets (ROA)	-40.55%	-13.99%	-47.99%	-45.54%	-42.76%	-27.92%
Return on Capital Employed (ROCE)	-51.40%	-16.80%	-70.20%	-98.60%	-76.10%	-46.60%
Earnings Yield	-14.01%	-8.51%	-19.63%	-19.69%	-29.68%	-7.72%
FCF Yield	-	-8.32%	-15.75%	-20.47%	-26.55%	-6.30%
Buyback Yield / Dilution	-104.85%	-41.72%	-33.71%	-3.64%	-28.44%	-26.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.